Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Ivabradine: the hope for a good treatment of ischemic heart disease.

Riccioni G.

Curr Med Chem. 2013;20(14):1817-23. Review.

PMID:
23394554
[PubMed - indexed for MEDLINE]
2.

Ivabradine: an intelligent drug for the treatment of ischemic heart disease.

Riccioni G.

Molecules. 2012 Nov 16;17(11):13592-604. doi: 10.3390/molecules171113592. Review.

PMID:
23159921
[PubMed - indexed for MEDLINE]
Free Article
3.

The benefits of ivabradine are independent of resting heart rate.

Riccioni G.

Future Cardiol. 2013 May;9(3):313-5. doi: 10.2217/fca.13.17.

PMID:
23668736
[PubMed]
4.

Ivabradine: beyond heart rate control.

Riccioni G, Vitulano N, D'Orazio N.

Adv Ther. 2009 Jan;26(1):12-24. doi: 10.1007/s12325-008-0130-y. Epub 2009 Jan 22. Review.

PMID:
19165437
[PubMed - indexed for MEDLINE]
5.

I(f) inhibition in cardiovascular diseases.

Thollon C, Vilaine JP.

Adv Pharmacol. 2010;59:53-92. doi: 10.1016/S1054-3589(10)59003-3. Review.

PMID:
20933199
[PubMed - indexed for MEDLINE]
6.
7.

Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.

Rosano GM, Vitale C, Volterrani M.

Adv Ther. 2010 Apr;27(4):202-10. doi: 10.1007/s12325-010-0030-9. Epub 2010 May 20. Review.

PMID:
20495895
[PubMed - indexed for MEDLINE]
8.

The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease.

Vilaine JP.

Pharmacol Res. 2006 May;53(5):424-34. Epub 2006 Mar 28. Review.

PMID:
16638639
[PubMed - indexed for MEDLINE]
9.

Ivabradine: from molecular basis to clinical effectiveness.

Riccioni G.

Adv Ther. 2010 Mar;27(3):160-7. doi: 10.1007/s12325-010-0014-9. Epub 2010 Apr 22. Review.

PMID:
20419486
[PubMed - indexed for MEDLINE]
10.

Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.

Belardinelli R.

Rev Port Cardiol. 2000 Nov;19 Suppl 5:V35-9. Review.

PMID:
11206102
[PubMed - indexed for MEDLINE]
11.
12.

Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.

Deedwania P.

Drugs. 2013 Sep;73(14):1569-86. doi: 10.1007/s40265-013-0117-0. Review.

PMID:
24065301
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.

Sulfi S, Timmis AD.

Int J Clin Pract. 2006 Feb;60(2):222-8. Review.

PMID:
16451297
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

API expert consensus document on management of ischemic heart disease.

Association of Physicians of India.

J Assoc Physicians India. 2006 Jun;54:469-80. Review.

PMID:
16909697
[PubMed - indexed for MEDLINE]
15.

Ivabradine: cardiovascular effects.

Rognoni A, Bertolazzi M, Macciò S, Rognoni G.

Recent Pat Cardiovasc Drug Discov. 2009 Jan;4(1):61-6. Review.

PMID:
19149708
[PubMed - indexed for MEDLINE]
16.

Heart rate slowing versus other pharmacological antianginal strategies.

Diaz A, Tardif JC.

Adv Cardiol. 2006;43:65-78. Review.

PMID:
16936473
[PubMed - indexed for MEDLINE]
17.

Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers.

Riccioni G, Prencipe G, Benvenuto A, Masciocco L, Ventra S, Rizzo U, Russi C, Speziale G.

Pharmacology. 2013;91(1-2):35-8. doi: 10.1159/000343631. Epub 2012 Nov 9.

PMID:
23146926
[PubMed - indexed for MEDLINE]
18.

[The discovery of the selective If current inhibitor ivabradine (Procoralan): a new therapeutic approach to ischemic heart disease].

Vilaine JP.

Med Sci (Paris). 2006 Jan;22(1):87-94. Review. French.

PMID:
16386229
[PubMed - indexed for MEDLINE]
19.

Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(5):1-70. Epub 2006 Mar 1.

PMID:
23074496
[PubMed]
Free PMC Article
20.

Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.

Bruguera Cortada J, Varela A.

Am J Cardiovasc Drugs. 2009;9 Suppl 1:9-12. doi: 10.2165/1153162-S0-000000000-00000. Review.

PMID:
20000882
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk